<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03377738</url>
  </required_header>
  <id_info>
    <org_study_id>BRISA II.EPOC-Tabaco</org_study_id>
    <nct_id>NCT03377738</nct_id>
  </id_info>
  <brief_title>Effectiveness of the Spirometry Test as a Motivational Tool for Quitting Tobacco in Primary Care</brief_title>
  <official_title>Randomized Clinical Trial About the Effectiveness of the Spirometry Test as a Motivational Tool for Quitting Tobacco in Primary Care</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>MurciaSalud</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Consejeria de sanidad.Direccion general de planificacion, ordenacion sanitaria y farmaceutica e investigacion.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is analyze if spirometry is a motivational element for changes in
      the cessation phases of the tobacco habit, compared with not done spirometry.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      According to data from the last INE health survey carried out in 2006, 31.4% of males and
      22.3 % of females smoked, in other words more than 26% of the population were smokers. In the
      Region of Murcia, according to the same Health Survey, the data are even higher than those of
      Spain, with figures for male smokers at 36.25% and 23.31% for women, with an overall
      prevalence rate of nearly 30%.

      In light of these data, it is necessary to carry out intervention to help tobacco cessation
      and in this regard,the 98% of smokers trying to quit on their own without any specific
      support do not achieve their goal.

      Interventions at Primary Care Consultations we have two useful tools at our disposal: One of
      these is brief advice It should be firm, understandable, individualized, verbal and direct.
      It should last between 3 and 5 minutes and be eminently positive, highlighting the advantages
      of becoming an ex-smoker. This intervention vs non intervention have an OR=1.69 (IC
      95%1.45-1.98). The other intervention we have in an intensive. This includes providing
      systematic anti-tobacco advice accompanied by written documentation and psychological support
      as well as the follow-up of patients in their dishabituation process, with a periodicity
      which varies according to different studies, although to do this more time will have to be
      dedicated in the consultation.

      As more intense intervention on these patients as efficacy obtained is higher, increasing
      abstinence rates significantly.

      Appropriate interventions based on stage of change are based on the transtheoretical model of
      Prochaska and DiClemente. Smokers are at one stage or another in terms of lesser or greater
      degree of motivation to quit being closely related to the phases of abandonment of tobacco.

      In addition to these tools, two other interventions have been studied which could be useful
      for increasing cessation rates. In this regard, a Cochrane review determined the efficiency
      of the evaluation of biomedical risks and different levels of assessment used as a cessation
      tool for quitting the tobacco habit. The information from eleven trials was analyzed and in
      three of them spirometry and co-oximetry were used as motivational elements for tobacco
      cessation. However, the results were inconclusive due to the heterogeneity of the studies,
      but concludes that it is possible to further improve the methodological quality of studies
      aimed at evaluating the effectiveness of biomedical risk assessment, including spirometry, as
      an aid to quit smoking. Other studies also seen as a considerable number of smokers get
      smoking quit after learning their spirometric results.

      For all of these reasons, it is necessary to carry out interventions which help to encourage
      tobacco habit cessation and in this regard this study has been designed, in which it is
      intended to assess spirometry , as a motivational element in the phase of tobacco cessation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 2011</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>- Number of cessations of the tobacco habit (%)</measure>
    <time_frame>2-3 weeks, 3 month and 6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>- Cessation phase of the tobacco habit (%)</measure>
    <time_frame>2-3 weeks, 3 month and 6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Score on the Richmond test for assessing motivation to quit smoking.</measure>
    <time_frame>2-3 weeks, 3 month and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fagerström test score to assess dependency.</measure>
    <time_frame>2-3 weeks, 3 month and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Carbon monoxide levels (CO) (co-oximetry).</measure>
    <time_frame>2-3 weeks, 3 month and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anthropometric variables: weight, size and body mass index Exposure to tobacco: nº packets/day.</measure>
    <time_frame>2-3 weeks, 3 month and 6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Tobacco Cessation</condition>
  <arm_group>
    <arm_group_label>anti-smoking therapy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>All patients will be given only an intervention for tobacco cessation which will depend on the individual's cessation phase</description>
  </arm_group>
  <arm_group>
    <arm_group_label>anti-smoking therapy + spirometry</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All patients will be given an intervention for tobacco cessation which will depend on the individual's cessation phase. In addition, in this group will be given a spirometry test as a motivational element for dishabituation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>spirometry</intervention_name>
    <description>All patients will be given an intervention for tobacco cessation which will depend on the individual's cessation phase and will be given a spirometry test as a motivational element for dishabituation.</description>
    <arm_group_label>anti-smoking therapy + spirometry</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  An active smoker

          -  Aged between 40 and 75 years

          -  No diagnosis of acute or chronic respiratory disease

        Exclusion Criteria:

          -  Serious or terminal diseases

          -  Limiting osteoarticular diseases

          -  Serious mental diseases: Psychosis

          -  Serious depressive disorder

          -  Neurosis

          -  Addiction to drugs/alcohol

          -  Displaced patients (not habitual residents)

          -  Pregnancy

          -  Spirometry carried out for any reason in the year prior to inclusion in the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>A Lopez-santiago, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Consejeria de sanidad y consumo, Direccion general de planificacion, ordenacion sanitaria y farmaceutica e investigacion.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fundación para la Formación e Investigación Sanitarias de la Región de Murcia</name>
      <address>
        <city>Murcia</city>
        <state>Region De Murcia</state>
        <zip>30003</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/mesh/68016540</url>
    <description>MeSH</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/mesh/68011320</url>
    <description>MeSH</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/mesh?term=spirometry</url>
    <description>MeSH</description>
  </link>
  <reference>
    <citation>Instituto Nacional de Estadística INE. Encuesta Nacional de Salud 2006.</citation>
  </reference>
  <reference>
    <citation>Ruiz CA, Pinedo AR, Miranda JA, Bermúdez JA. [Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) annual campaign for 2007: the year for smoking prevention and control]. Arch Bronconeumol. 2007 Aug;43(8):423-4. Spanish.</citation>
    <PMID>17692241</PMID>
  </reference>
  <reference>
    <citation>Saiz Martínez-Acitores I, Rubio Colavida J, Espiga López I, Alonso de la Iglesia B, Blanco Aguilar J, Cortés Mancha M, Cabrera Ortega JD, Pont Martínez P, Saavedra Rodríguez JM, Toledo Pallarés J. [National Action Plan for Prevention and Tobacco Control]. Rev Esp Salud Publica. 2003 Jul-Aug;77(4):441-73. Spanish.</citation>
    <PMID>12945131</PMID>
  </reference>
  <reference>
    <citation>Banegas JR, Díez Gañán L, González Enríquez J, Villar Alvarez F, Rodríguez-Artalejo F. [Recent decrease in smoking-attributable mortality in Spain]. Med Clin (Barc). 2005 May 28;124(20):769-71. Spanish.</citation>
    <PMID>15927102</PMID>
  </reference>
  <reference>
    <citation>Villalbí JR, Castillo A, Cleries M, Saltó E, Sánchez E, Martínez R, Tresserras R, Vela E; Barcelona Group. Acute myocardial infarction hospitalization statistics: apparent decline accompanying an increase in smoke-free areas. Rev Esp Cardiol. 2009 Jul;62(7):812-5. English, Spanish.</citation>
    <PMID>19709517</PMID>
  </reference>
  <reference>
    <citation>Fernández E, Fu M, Pascual JA, López MJ, Pérez-Ríos M, Schiaffino A, Martínez-Sánchez JM, Ariza C, Saltó E, Nebot M; Spanish Smoking Law Evaluation Group. Impact of the Spanish smoking law on exposure to second-hand smoke and respiratory health in hospitality workers: a cohort study. PLoS One. 2009;4(1):e4244. doi: 10.1371/journal.pone.0004244. Epub 2009 Jan 23.</citation>
    <PMID>19165321</PMID>
  </reference>
  <reference>
    <citation>Martínez-Sánchez JM, Fernández E, Fu M, Pérez-Ríos M, López MJ, Ariza C, Pascual JA, Schiaffino A, Pérez-Ortuño R, Saltó E, Nebot M. Impact of the Spanish smoking law in smoker hospitality workers. Nicotine Tob Res. 2009 Sep;11(9):1099-106. doi: 10.1093/ntr/ntp107. Epub 2009 Jul 29.</citation>
    <PMID>19640834</PMID>
  </reference>
  <reference>
    <citation>Silagy C. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2000;(2):CD000165. Review. Update in: Cochrane Database Syst Rev. 2001;(2):CD000165.</citation>
    <PMID>10796499</PMID>
  </reference>
  <reference>
    <citation>Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel, Liaisons, and Staff. A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report. Am J Prev Med. 2008 Aug;35(2):158-76. doi: 10.1016/j.amepre.2008.04.009. Review.</citation>
    <PMID>18617085</PMID>
  </reference>
  <reference>
    <citation>Sanz Pozo B, de Miguel Díez J, Camarelles Guillem F. [Non-pharmacological methods in tobacco dishabituation]. Rev Clin Esp. 2004 Jan;204(1):37-9. Spanish.</citation>
    <PMID>14746762</PMID>
  </reference>
  <reference>
    <citation>Kottke TE, Battista RN, DeFriese GH, Brekke ML. Attributes of successful smoking cessation interventions in medical practice. A meta-analysis of 39 controlled trials. JAMA. 1988 May 20;259(19):2883-9.</citation>
    <PMID>3367456</PMID>
  </reference>
  <reference>
    <citation>Camarelles Guillem F, Salvador Llivina T, Ramón Torell JM, Córdoba García R, Jiménez Ruiz C, López García-Aranda V, Villalbí Hereter JR, Planchuelo Santos MA, Sánchez Monfort J, López de Santiago A. [Consensus on health assistance for smoking control in Spain]. Rev Esp Salud Publica. 2009 Mar-Apr;83(2):175-200. Spanish.</citation>
    <PMID>19626247</PMID>
  </reference>
  <reference>
    <citation>F. Marqués Molías, et al. Recomendaciones sobre el estilo de vida. Grupo de Educación para la Salud del PAPPS. actualizacion 2009. acceso (23/03/2011): http://www.papps.org/upload/file/08%20PAPPS%20ACTUALIZACION%202009.pdf</citation>
  </reference>
  <reference>
    <citation>Javier Mataix Sancho et al. Guia para el tratamiento del tabaquismo activo y pasivo. segunda edicion 2009. accesso (24/03/2011): http://www.papps.org/upload/file/publicaciones/Guia%20Tabaquismo2009.pdf.</citation>
  </reference>
  <reference>
    <citation>Martín Cantera C, Córdoba García R, Jane Julio C, Nebot Adell M, Galán Herrera S, Aliaga M, Pujol Ribera E, Ballestín M. [Mid-term evaluation of a help program for smokers]. Med Clin (Barc). 1997 Nov 29;109(19):744-8. Spanish.</citation>
    <PMID>9470183</PMID>
  </reference>
  <reference>
    <citation>Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol. 1983 Jun;51(3):390-5.</citation>
    <PMID>6863699</PMID>
  </reference>
  <reference>
    <citation>Prochaska JO, Velicer WF, DiClemente CC, Fava J. Measuring processes of change: applications to the cessation of smoking. J Consult Clin Psychol. 1988 Aug;56(4):520-8.</citation>
    <PMID>3198809</PMID>
  </reference>
  <reference>
    <citation>Bize R, Burnand B, Mueller Y, Rège Walther M, Cornuz J. Biomedical risk assessment as an aid for smoking cessation. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD004705. doi: 10.1002/14651858.CD004705.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;12:CD004705.</citation>
    <PMID>19370604</PMID>
  </reference>
  <reference>
    <citation>Clotet J, Gómez-Arbonés X, Ciria C, Albalad JM. [Spirometry is a good method for detecting and monitoring chronic obstructive pulmonary disease in high-risk smokers in primary health care]. Arch Bronconeumol. 2004 Apr;40(4):155-9. Spanish.</citation>
    <PMID>15030729</PMID>
  </reference>
  <reference>
    <citation>Czajkowska-Malinowska M, Nowiński A, Górecka D, Zieliński J. [Effects of spirometric screening in the community on smoking cessation]. Pneumonol Alergol Pol. 2001;69(9-10):524-9. Polish.</citation>
    <PMID>11928658</PMID>
  </reference>
  <reference>
    <citation>Risser NL, Belcher DW. Adding spirometry, carbon monoxide, and pulmonary symptom results to smoking cessation counseling: a randomized trial. J Gen Intern Med. 1990 Jan-Feb;5(1):16-22.</citation>
    <PMID>2405112</PMID>
  </reference>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 22, 2011</study_first_submitted>
  <study_first_submitted_qc>December 14, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 19, 2017</study_first_posted>
  <last_update_submitted>December 14, 2017</last_update_submitted>
  <last_update_submitted_qc>December 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Spirometry</keyword>
  <keyword>Primary care</keyword>
  <keyword>Smoking Cessations</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

